LifeMD annual return on equity
2013
2014
2017
2018
2021
2022
2025
LifeMD Return on Equity (ROE) Growth & History (LFMD)
LifeMD's return on equity was 203.99% for fiscal 2025.
View full LifeMD company overviewLifeMD annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 203.99% | — |
| 2022 | 2022-12-31 | −802.80% | −206.87 pp |
| 2021 | 2021-12-31 | −595.92% | — |
| 2018 | 2018-12-31 | −139.45% | +318.44 pp |
| 2017 | 2017-12-31 | −457.88% | — |
| 2014 | 2014-12-31 | −1,644.91% | −1482.57 pp |
| 2013 | 2013-12-31 | −162.34% | — |
LifeMD quarterly return on equity
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q1.16
Q2.16
Q3.16
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q4.21
Q1.22
Q2.22
Q3.22
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −61.59% | — |
| Q1 2026 | 2026-03-31 | −46.46% | — |
| Q4 2025 | 2025-12-31 | 163.16% | — |
| Q3 2022 | 2022-09-30 | −494.93% | — |
| Q2 2022 | 2022-06-30 | −156.05% | — |
| Q1 2022 | 2022-03-31 | −74.06% | — |
| Q4 2021 | 2021-12-31 | −698.99% | — |
| Q1 2019 | 2019-03-31 | −101.94% | −164.19 pp |
| Q4 2018 | 2018-12-31 | −30.06% | −4.22 pp |
| Q3 2018 | 2018-09-30 | −38.60% | +164.65 pp |
| Q2 2018 | 2018-06-30 | −85.62% | — |
| Q1 2018 | 2018-03-31 | 62.25% | — |
| Q4 2017 | 2017-12-31 | −25.84% | — |
| Q3 2017 | 2017-09-30 | −203.25% | −124.85 pp |
| Q3 2016 | 2016-09-30 | −78.40% | — |
| Q2 2016 | 2016-06-30 | −112.62% | — |
| Q1 2016 | 2016-03-31 | −70.12% | — |
| Q2 2014 | 2014-06-30 | −147.29% | −136.75 pp |
| Q1 2014 | 2014-03-31 | −101.38% | −68.91 pp |
| Q4 2013 | 2013-12-31 | −60.57% | — |
| Q3 2013 | 2013-09-30 | −126.15% | — |
| Q2 2013 | 2013-06-30 | −10.55% | — |
| Q1 2013 | 2013-03-31 | −32.47% | — |
LifeMD return on equity trends
Between the periods ended 2013-12-31 and 2025-12-31, LifeMD's return on equity increased from −162.34% to 203.99%, a change of +366.33 percentage points. The latest reported quarter, Q2 2026, shows −61.59%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review LifeMD source filings ↗